Article | November 4, 2021

Paving The Way Towards Carbon Neutral eCOA Trials

Source: Kayentis
eCOA Resources Overview

COVID-19 led businesses to adopt new practices, including moving many operations online and leading to a positive impact on CO2 emission reductions. The clinical trials industry is no exception and is also able to accommodate such change. The timing is right to introduce additional carbon-efficient solutions to clinical trials. This article explores on how to improve eCOA trials carbon footprint.

To learn more about Kayentis, visit


access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader